3-Aroyl-1-ethoxycarbonylmethyl-2-methylisothioureas and 2-aroylimino-4 -ethoxycarbonyl-hexahydropyrimidin-5-ones were synthesized from dimethyl N-aroylcarbonimidodithioates and glycine ethyl ester.
Pharmaceutically active compounds and methods of use
申请人:Scion Pharmaceuticals, Inc.
公开号:US07041702B1
公开(公告)日:2006-05-09
The present invention relates to pharmaceutically acceptable compounds, including acylguanidine compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are particularly useful for the treatment or prophylaxis of neurological injury and neurodegenerative disorders.